Laractone en es it fr

Laractone Brand names, Laractone Analogs

Laractone Brand Names Mixture

  • No information avaliable

Laractone Chemical_Formula

C33H30N4O2

Laractone RX_link

http://www.rxlist.com/cgi/generic2/telmisartan.htm

Laractone fda sheet

Laractone FDA

Laractone msds (material safety sheet)

Laractone MSDS

Laractone Synthesis Reference

No information avaliable

Laractone Molecular Weight

514.617 g/mol

Laractone Melting Point

261-263oC

Laractone H2O Solubility

Practically insoluble

Laractone State

Solid

Laractone LogP

7.245

Laractone Dosage Forms

Tablets

Laractone Indication

For the treatment of hypertension.

Laractone Pharmacology

Telmisartan is an orally active nonpeptide angiotensin II antagonist that acts on the AT1 receptor subtype. New studies suggest that telmisartan may also have PPARγ agonistic properties that could potentially confer beneficial metabolic effects. This observation is currently being explored in clinical trials. Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium. Telmisartan works by blocking the vasoconstrictor and aldosterone secretory effects of angiotensin II.

Laractone Absorption

Absolute bioavailability depends on dosage. Food slightly decreases the bioavailability (a decrease of about 6% is seen when the 40-mg dose is administered with food).

Laractone side effects and Toxicity

Intravenous LD50 in rats is 150-200 mg/kg in males and 200 to 250 mg/kg in females. Acute oral toxicity is low: no deaths and no changes occurred in rats or dogs at 2000 mg/kg, the highest dose tested. Limited data are available with regard to overdosage in humans. The most likely manifestations of overdosage with telmisartan would be hypotension, dizziness and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation.

Laractone Patient Information

Laractone Organisms Affected

Humans and other mammals